Glucotrack (GCTK) Operating Expenses (2010 - 2025)

Glucotrack has disclosed Operating Expenses across 15 years of filings, most recently posting $3.5 million for Q4 2025.

• Quarterly Operating Expenses fell 9.52% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.1 million (up 10.61% YoY) and the FY2025 annual result came in at $16.1 million, up 10.61% from the prior year.
• Operating Expenses fell to $3.5 million in Q4 2025, from $4.3 million in the prior quarter.
• Over five years, Operating Expenses peaked at $4.8 million in Q2 2025 and troughed at $767000.0 in Q3 2021.
• A 5-year average of $2.3 million and a median of $1.9 million in 2021 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses dropped 14.43% — and 2024, when it surged 280.92%.
• Tracing GCTK's Operating Expenses over 5 years: stood at $1.5 million in 2021, then fell by 14.43% to $1.3 million in 2022, then surged by 87.8% to $2.4 million in 2023, then jumped by 59.45% to $3.9 million in 2024, then retreated by 9.52% to $3.5 million in 2025.
• Business Quant data shows GCTK's Operating Expenses at $3.5 million in Q4 2025, $4.3 million in Q3 2025, and $4.8 million in Q2 2025.